Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients".
Calandra
Thierry
T
Marchetti
Oscar
O
D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000150:complications / Q000517:prevention & control*; D016638:Critical Illness; D006801:Humans; D013557:Switzerland
D000935:Antifungal Agents